TRCT
INBS icon

Tower Research Capital (TRC)’s Intelligent Bio Solutions INBS Stock Holding History

Tower Research Capital (TRC)’s Portfolio INBS Stock Details INBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.53K Buy
3,280
+2,030
+162% +$5.34K ﹤0.01% 4127
2026
Q1 		$4.18K Sell
1,250
-10
-0.8% -$69 ﹤0.01% 4225
2025
Q4 		$12K Buy
+1,260
New +$10.3K ﹤0.01% 3524
2025
Q1 		– Sell
-580
Closed -$8.12K – 5483
2024
Q4 		$8.12K Buy
580
+474
+447% +$7.23K ﹤0.01% 4022
2024
Q3 		$1.84K Buy
106
+41
+63% +$639 ﹤0.01% 5097
2024
Q2 		$1.26K Sell
65
-40
-38% -$1.02K ﹤0.01% 5180
2024
Q1 		$4.43K Sell
105
-106
-50% -$4.39K ﹤0.01% 4681
2023
Q4 		$8.57K Buy
211
+161
+322% +$6.33K ﹤0.01% 4497
2023
Q3 		$6.12K Buy
50
+25
+100% +$5.67K ﹤0.01% 4641
2023
Q2 		$8.41K Buy
25
+1
+4% +$346 ﹤0.01% 4435
2023
Q1 		$8K Buy
+24
New +$22K ﹤0.01% 4635
2022
Q4 		– Hold
0
– – – 6126
2022
Q2 		– Sell
-2
Closed -$3K – 6279
2022
Q1 		$3K Hold
2
– – ﹤0.01% 5374
2021
Q4 		$8K Buy
2
+1
+100% +$4.59K ﹤0.01% 4791
2021
Q3 		$8K Hold
1
– – ﹤0.01% 4540
2021
Q2 		$14K Hold
1
– – ﹤0.01% 4177
2021
Q1 		$7K Buy
+1
New +$17.2K ﹤0.01% 4530

Other funds holding INBS

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Tower Research Capital (TRC)'s INBS Position: Q2 2026 in Review

Tower Research Capital (TRC) increased its Intelligent Bio Solutions (INBS) stake by 162% in Q2 2026, buying an estimated $5.34K and bringing the position to 3,280 shares worth $7.53K. The position accounts for ﹤0.01% of the portfolio, ranked #4127.

Tower Research Capital (TRC) first reported a position in INBS in Q1 2021 and has held it in 16 quarters since. The position peaked at $14K in Q2 2021. 8 funds tracked by Wall St. Rank hold INBS as of Q2 2026.

  • Tower Research Capital (TRC) held 3,280 shares of Intelligent Bio Solutions worth $7.53K as of Q2 2026.
  • Tower Research Capital (TRC) bought 2,030 Intelligent Bio Solutions shares in Q2 2026, an estimated $5.34K.
  • Intelligent Bio Solutions made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #4127 holding.
  • Tower Research Capital (TRC) first reported a position in Intelligent Bio Solutions in Q1 2021 and has held it in 16 quarters since.
  • Tower Research Capital (TRC)'s Intelligent Bio Solutions position peaked at $14K in Q2 2021.
  • 8 funds tracked by Wall St. Rank held Intelligent Bio Solutions as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.